BFC vs RXRX

Comparison between Bank First Corp (BFC, Company) and Recursion Pharmaceuticals Inc - Class A (RXRX, Company).

BFC is from the Financial Services sector, while RXRX is from the Healthcare sector.

5-Year PerformanceBFC has outperformed RXRX, delivering a return of +17.7% compared to -36.8%

BFC vs RXRX - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	BFC(COMPANY)	RXRX(COMPANY)
Market Cap	$1.61B	$1.61B
Max Drawdown	82.02%	93.13%
Sharpe Ratio	0.86	-0.46
5Y Beta	0.65	2.62
Industry	Banks - Regional	Biotechnology
P/E Ratio	19.99	-2.64
Forward P/E	5.81	N/A
PEG Ratio	3.78	N/A
Dividend Yield	1.28%	N/A
5Y Dividends CAGR	47.88%	N/A
5Y EPS CAGR	5.62%	-10.03%
Debt to Equity	0.00%	0.00%
Free Cash Flow Yield	1.87%	-20.20%
P/S Ratio	8.34	24.06
P/B Ratio	1.97	1.57

Market Cap

Winner

BFC

$1.61B

RXRX

$1.61B

Max Drawdown

Winner

BFC

82.02%

RXRX

93.13%

Sharpe Ratio

Winner

BFC

0.86

RXRX

-0.46

5Y Beta

Winner

BFC

0.65

RXRX

2.62

Industry

BFC

Banks - Regional

RXRX

Biotechnology

P/E Ratio

BFC

19.99

Winner

RXRX

-2.64

Forward P/E

BFC

5.81

RXRX

N/A

PEG Ratio

BFC

3.78

RXRX

N/A

Dividend Yield

BFC

1.28%

RXRX

N/A

5Y Dividends CAGR

BFC

47.88%

RXRX

N/A

5Y EPS CAGR

Winner

BFC

5.62%

RXRX

-10.03%

Debt to Equity

BFC

0.00%

RXRX

0.00%

Free Cash Flow Yield

Winner

BFC

1.87%

RXRX

-20.20%

P/S Ratio

Winner

BFC

8.34

RXRX

24.06

P/B Ratio

BFC

1.97

Winner

RXRX

1.57

BFC vs RXRX - Historical Returns

Returns include dividend reinvestment.

Period	BFC	RXRX
1 month	+0.60%	+0.00%
3 months	+8.16%	-4.26%
6 months	+8.10%	-27.25%
1 year	+27.40%	-39.07%
5 years(CAGR)	+17.73%	-36.78%
10 years(CAGR)	+20.11%	N/A
Max(CAGR)	+8.61%	-35.94%

Winner

BFC

+0.60%

RXRX

+0.00%

Winner

BFC

+8.16%

RXRX

-4.26%

Winner

BFC

+8.10%

RXRX

-27.25%

Winner

BFC

+27.40%

RXRX

-39.07%

5Y(CAGR)

Winner

BFC

+17.73%

RXRX

-36.78%

10Y(CAGR)

BFC

+20.11%

RXRX

N/A

Max(CAGR)

Winner

BFC

+8.61%

RXRX

-35.94%

BFC vs RXRX - Annual Returns (2002 - 2026)

Returns include dividend reinvestment.

Year	BFC	RXRX
2026	+20.79%	-25.00%
2025	+30.77%	-43.27%
2024	+16.13%	-31.51%
2023	-4.01%	+30.60%
2022	+30.94%	-57.24%
2021	+12.46%	-45.27%
2020	-5.91%	N/A
2019	+47.63%	N/A
2018	+5.70%	N/A
2017	+37.31%	N/A
2016	+27.13%	N/A
2015	+28.05%	N/A
2014	+21.22%	N/A
2013	+26.17%	N/A
2012	+17.36%	N/A
2011	+20.19%	N/A
2010	+35.47%	N/A
2009	-15.60%	N/A
2008	-19.26%	N/A
2007	-16.01%	N/A
2006	-7.54%	N/A
2005	+15.48%	N/A
2004	+1.64%	N/A
2003	+5.17%	N/A
2002	-48.21%	N/A

BFC vs RXRX Drawdown Comparison

The maximum drawdown for BFC was -82.02%, occurring on Feb 18, 2009. Recovery took 3198 trading sessions.

The maximum drawdown for RXRX was -93.13%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The current BFC drawdown is -4.04%. The current RXRX drawdown is -92.38%.

Rank	BFC	RXRX
#1	-82.02% Sep 13, 2002 - Jun 1, 2015	-93.13% Jul 13, 2021 - Mar 30, 2026
#2	-39.78% Jun 12, 2019 - Mar 8, 2021	-38.10% Apr 29, 2021 - Jun 17, 2021
#3	-32.75% Nov 25, 2022 - Oct 17, 2024	-10.54% Apr 16, 2021 - Apr 21, 2021
#4	-20.02% Apr 30, 2018 - Mar 7, 2019	-10.45% Jun 21, 2021 - Jul 6, 2021
#5	-14.17% Feb 9, 2026 - Mar 20, 2026	-8.29% Apr 21, 2021 - Apr 29, 2021
#6	-13.46% Dec 11, 2024 - Apr 21, 2025	N/A
#7	-12.65% Jul 23, 2025 - Oct 6, 2025	N/A
#8	-12.09% Mar 12, 2021 - Jun 24, 2022	N/A
#9	-11.75% Oct 14, 2025 - Dec 11, 2025	N/A
#10	-11.30% Dec 30, 2015 - May 3, 2016	N/A
#11	-11.07% Dec 11, 2025 - Jan 21, 2026	N/A
#12	-7.55% May 30, 2019 - Jun 11, 2019	N/A
#13	-7.23% Nov 25, 2015 - Dec 30, 2015	N/A
#14	-7.08% Aug 18, 2022 - Oct 21, 2022	N/A
#15	-7.07% Jun 24, 2015 - Nov 6, 2015	N/A

Correlation

Correlation between BFC and RXRX is -0.55 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.55

-101